R01 CA110249/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	2
2007	6
2008	15
2009	17
2010	12
2011	13
2012	7
2013	9
2014	11
2015	4
2016	3
2017	3
2018	1
2025	0

1

CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.

Price MA, Colvin Wanshura LE, Yang J, Carlson J, Xiang B, Li G, Ferrone S, Dudek AZ, Turley EA, McCarthy JB. Price MA, et al. Pigment Cell Melanoma Res. 2011 Dec;24(6):1148-57. doi: 10.1111/j.1755-148X.2011.00929.x. Pigment Cell Melanoma Res. 2011. PMID: 22004131 Free PMC article. Review.

2

Immunotherapy of cancer in 2012.

Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Kirkwood JM, et al. CA Cancer J Clin. 2012 Sep-Oct;62(5):309-35. doi: 10.3322/caac.20132. Epub 2012 May 10. CA Cancer J Clin. 2012. PMID: 22576456 Free PMC article. Review.

3

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Campoli M, Ferrone S. Campoli M, et al. Oncogene. 2008 Oct 6;27(45):5869-85. doi: 10.1038/onc.2008.273. Oncogene. 2008. PMID: 18836468 Free PMC article. Review.

4

The complex role of B7 molecules in tumor immunology.

Seliger B, Marincola FM, Ferrone S, Abken H. Seliger B, et al. Trends Mol Med. 2008 Dec;14(12):550-9. doi: 10.1016/j.molmed.2008.09.010. Epub 2008 Nov 3. Trends Mol Med. 2008. PMID: 18986838 Free PMC article. Review.

5

Oncogenic growth factor signaling mediating tumor escape from cellular immunity.

Concha-Benavente F, Ferris RL. Concha-Benavente F, et al. Curr Opin Immunol. 2017 Apr;45:52-59. doi: 10.1016/j.coi.2017.01.004. Epub 2017 Feb 14. Curr Opin Immunol. 2017. PMID: 28208102 Free PMC article. Review.

6

Functional and clinical relevance of chondroitin sulfate proteoglycan 4.

Campoli M, Ferrone S, Wang X. Campoli M, et al. Adv Cancer Res. 2010;109:73-121. doi: 10.1016/B978-0-12-380890-5.00003-X. Adv Cancer Res. 2010. PMID: 21070915 Review.

7

Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.

Campoli M, Ferris R, Ferrone S, Wang X. Campoli M, et al. Clin Cancer Res. 2010 Jan 1;16(1):11-20. doi: 10.1158/1078-0432.CCR-09-2345. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028761 Free PMC article. Review.

8

Cancer immunotherapy: Progress and challenges in the clinical setting.

Zarour HM, Ferrone S. Zarour HM, et al. Eur J Immunol. 2011 Jun;41(6):1510-5. doi: 10.1002/eji.201190035. Eur J Immunol. 2011. PMID: 21618503 Free PMC article. Review. No abstract available.

9

Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells.

Concha-Benavente F, Srivastava R, Ferrone S, Ferris RL. Concha-Benavente F, et al. Oral Oncol. 2016 Jul;58:52-8. doi: 10.1016/j.oraloncology.2016.05.008. Epub 2016 Jun 2. Oral Oncol. 2016. PMID: 27264839 Free PMC article. Review.

10

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.

Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, Capanni M, Umansky V, Paschen A, Sucker A, Pende D, Groh V, Biassoni R, Höglund P, Kato M, Shibuya K, Schadendorf D, Anichini A, Ferrone S, Velardi A, Kärre K, Shibuya A, Carbone E, Colucci F. Lakshmikanth T, et al. J Clin Invest. 2009 May;119(5):1251-63. doi: 10.1172/JCI36022. Epub 2009 Apr 6. J Clin Invest. 2009. PMID: 19349689 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Results by year